Mesalazin Orion

Mesalazine, the active ingredient in Mesalazin Orion, is an aminosalicylate presented as an oral formulation for oral use. It is employed to treat inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease in adult patients, helping to reduce intestinal inflammation and maintain remission.

GNH USA supplies Mesalazin Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU manufacturing standards and providing reliable global distribution. The company ensures product integrity through rigorous quality control.

Mesalazine is used primarily in the management of inflammatory bowel disease, targeting the colon and rectum.

- Ulcerative colitis: reduces mucosal inflammation and induces remission. - Crohn’s disease (colonic involvement): alleviates intestinal inflammation and supports symptom control. - Maintenance of remission: helps prevent disease flare‑ups after induction therapy.

Mesalazine may be associated with a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild to moderate intensity. - Nausea: occasional, often transient. - Abdominal pain: cramping or discomfort. - Flatulence: increased intestinal gas. - Rash: mild skin irritation. - Diarrhoea: loose stools.

Serious or Rare Side Effects: - Myocarditis or pericarditis: inflammation of heart tissues. - Severe liver injury: marked elevation of hepatic enzymes. - Blood dyscrasias: neutropenia, thrombocytopenia. - Stevens‑Johnson syndrome: severe skin reaction. - Pancreatitis: inflammation of the pancreas. - Renal impairment: reduced kidney function.

Patients should be monitored for safety and appropriate use of Mesalazin Orion.

- Renal function: assess baseline and periodic creatinine levels. - Hepatic function: monitor liver enzymes during therapy. - Blood counts: perform regular complete blood count checks. - Hypersensitivity: discontinue if rash, fever, or systemic reactions occur. - Pregnancy and lactation: discuss risks with a healthcare professional before use. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Mesalazin Orion can interact with several medicines; awareness helps minimize risk.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Azathioprine or 6‑mercaptopurine: heightened myelosuppression. - Sulfasalazine: additive toxicity, especially renal.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may worsen renal function. - ACE inhibitors or diuretics: monitor renal parameters. - Oral contraceptives: potential for increased thrombotic risk. - High‑dose vitamin C: may affect absorption.